Does ROTIGOTINE Cause Product dose omission issue? 209 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 209 reports of Product dose omission issue have been filed in association with ROTIGOTINE (Neupro). This represents 2.7% of all adverse event reports for ROTIGOTINE.
209
Reports of Product dose omission issue with ROTIGOTINE
2.7%
of all ROTIGOTINE reports
2
Deaths
21
Hospitalizations
How Dangerous Is Product dose omission issue From ROTIGOTINE?
Of the 209 reports, 2 (1.0%) resulted in death, 21 (10.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROTIGOTINE. However, 209 reports have been filed with the FAERS database.
What Other Side Effects Does ROTIGOTINE Cause?
Product adhesion issue (1,718)
Off label use (646)
Drug ineffective (632)
Death (595)
Parkinson's disease (419)
Fall (412)
Device adhesion issue (383)
Overdose (353)
Application site pruritus (334)
Application site erythema (330)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ROTIGOTINE Alternatives Have Lower Product dose omission issue Risk?
ROTIGOTINE vs ROXADUSTAT
ROTIGOTINE vs ROXICODONE
ROTIGOTINE vs ROXITHROMYCIN
ROTIGOTINE vs ROZANOLIXIZUMAB
ROTIGOTINE vs ROZANOLIXIZUMAB-NOLI